Call for Abstract
18th Global Biomarkers and Clinical Research Summit, will be organized around the theme “Future of Medical Diagnosis and Treatment”
Biomarkers 2022 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Biomarkers 2022
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Biomarkers are the measures
Molecular biomarkers are often estimate from the molecules of particular sample which indicates the presence of disease or diseased state physiological change response to a treatment or physiological state.It has the collection of techniques to analyse from genomics and proteomics within the individual ordering.These are often performed by the action of applying biology into medical testing
- Nucleic acid-based Biomarkers
- Proteomic Biomarkers
- Genomic Biomarkers
- Blood based Biomarker
- Small molecule Biomarkers
- Lipid Biomarkers
- microRNA Biomarkers
- Transcriptomic Biomarkers
This biomarker conference throws light on the use of biomarkers in drug development which has the use of biomarkers as surrogate end points for effectiveness. Biomarkers enhances is the understanding of the mechanism of action, enables the assessment of target engagement, facilitates early proof of dose focusing and increases the efficiency of early clinical development with improved quality of deciding , these concepts help within the drug discovery and development process.
Clinical research biomarkers which are used for clinical purposes are referred to as clinical biomarkers. Clinical biomarkers provide active and influential way to understanding the scope of the many diseases and epidemiology, random clinical trials, screening for drugs or disease diagnosis and prognosis. It is defined as changes within the constituents of cells or body fluids, these clinical biomarkers offer the means for standardized classification of a disease and risk factors that can extend the essential information about the underlying pathogenesis of diseases. The main researches in clinical biomarkers are tired the fields of drug discovery, pharmacogenomics, oncology, and disease diagnostics. Classes of Biomarkers in Clinical trials are segmented into Safety biomarkers and Efficacy biomarkers.
Digital biomarkers says that the objective, quantifiable physiological and behavioral data that are gathered and measured by means of digital devices like portables, wearables, implantables, or digestibles. The data collected are typically wont to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent a chance to capture clinically meaningful, objective data.
Genomics and Clinical development promise the event of biomarkers to a state to predict the danger of individual disease that permits early detection of the disease and improves diagnostic classification to better inform individualized treatment.Biomarkers are biological measurements which will be wont to predict the danger of diseases,to permit early detection of diseases, to enhance the choice of treatment and to watch the outcome of therapeutic interventions.The main objective of the Human Genome Project was the identification and development of biomarkers for "personalized, preventive and predictive medicine”. This clinical conference focuses on biomarkers incorporating within the gene level into earlier stages of the clinical trials which help to separate the patients and help within the development of the biomarker and just in case of clinical development this incorporation serves in multiple ways from guiding dose selection to selecting the mode of action to providing the strategy to know about to whom the a specific biomarker are often used.Digital Biomarkers
A cancer biomarker is a substance that's indicative of the presence of cancer within the body. A biomarker could also be a molecule secreted by a tumor or a selected response of the body to presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers are often used for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers are often used to predict how violently your cancer will grow, and are therefore useful for assessing your prognosis, the foremost promising use of biomarkers today is to spot which therapies a patient’s cancer may or might not answer .
Biomedical Engineering is that the application of engineering principles to the fields of biology and health care. Bioengineers work with doctors, therapists and researchers to implement systems, equipment and devices so as to unstitch clinical problems which specialise in the development that improve human health and health care at all levels. Clinical engineering even be a special field within Biomedical engineering responsible primarily for applying and implementing medical technology to optimize health health care delivery.